Shehnaaz Suliman is the founder of ReCode Therapeutics. ReCode Therapeutics has raised $570M, latest Series B $29M (2025). Biotech · Menlo Park, CA.
Shehnaaz Suliman is the founder of ReCode Therapeutics. ReCode Therapeutics operates in Biotech and is based in Menlo Park, CA. ReCode Therapeutics has raised $570M, latest Series B $29M (2025). Backers on record include Angela Ni, Bioluminescence Ventures.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Menlo Park — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library